The Market Reports

SynopsisThe global TMS Neuronavigation Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for TMS Neuronavigation Systems is estimat.....

SynopsisThe global Proteasome Inhibitors for Multiple Myeloma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Proteasome Inhibitors f.....

SynopsisAcute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances o.....

SynopsisA High-throughput Pipetting system refers to an automated platform designed to accurately dispense precise volumes of liquid samples into various types of containers or well plates (such as 96-well plate) used in scientific experiments requiring many repetitiv.....

SynopsisGlobal Electric Pneumatic Pediatric Nebulizer market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukr.....

SynopsisThe global Muscle Stimulators market was valued at US$ 696.3 million in 2023 and is anticipated to reach US$ 884.2 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030. North American market for Muscle Stimulators is estimated .....

SynopsisTestosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for t.....

SynopsisCardiovascular disease (CVD) is a group of diseases that include both the heart and blood vessels, thereby including coronary heart disease (CHD) and coronary artery disease (CAD), and acute coronary syndrome (ACS) among several other conditions.  The gl.....

SynopsisAmbrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension. It is approved in Europe, Canada and the United States for use as a single agent to improve exercise ability and del.....

SynopsisIn general, it can selectively absorb blood and liquid with different solubility for each component of gas mixture. The global Blood and Bodily Fluid Absorbent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029.....